Hydroxyurea Capsules IP

PRODUCT INTRODUCTION

Hydroxyurea Capsule is used in the treatment of some kinds of cancer and to prevent painful episodes associated with sickle cell anemia. It may be also used to treat some other conditions. It is sometimes used with certain other medicines as part of combination chemotherapy.

Hydroxyurea Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

USES OF  HYDROXYUREA CAPSULE

·        Head and neck cancer

·        Sickle cell anemia

BENEFITS OF  HYDROXYUREA CAPSULE In Head and neck cancer

Head and neck cancer includes cancer of the mouth, nose, sinuses or throat.  Hydroxyurea Capsule kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

In Sickle cell anemia

Sickle cell anemia is a disorder of the red blood cells (RBCs) in which they lose their original round shape and flexibility, turn sickle shape and eventually die out.  Hydroxyurea Capsule makes your red blood cells bigger. It helps them stay rounder and more flexible and makes them less likely to turn into a sickle shape. The medicine does this by increasing a special kind of hemoglobin called hemoglobin F. Hemoglobin F is also called fetal hemoglobin because newborn babies have it. This helps to treat this disease and also prevents further complications that may be life-threatening.